The company must pay nearly $450 million for illegally blocking generic competition to the testosterone product with “baseless” patent litigation, a judge said.
Pharmaceutical Care
Management Association
325 7th Street, NW
Washington, DC 20004
Main: 202.756.5700
©2024 PCMA. All Rights Reserved.